Skip to content

Effect on the QOL related to sleep by amino acids intake to healthy adult male and female.

Effect on the QOL related to sleep by amino acids intake to healthy adult male and female. - Effect on the QOL related to sleep by amino acids intake.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034664
Enrollment
60
Registered
2018-10-26
Start date
2018-10-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of food containing amino acids for 1 week Intake of food containing amino acids and L-theanine for 1 week Intake of placebo food for 1 week

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy adult male and female workers from 20 to 64 years of age (2) The total score of the Zc of OSA sleep inventory MA version is low

Exclusion criteria

Exclusion criteria: (1) Subjects who constantly use health food richly containing involvement ingredient (2) Subjects who perform an act for the improvement of the quality of the sleep, the stress, and fatigue (3) Subjects whose BMI are 30.0 kg/m^2 or more (4) Subjects who wake up halfway or more due to nighttime urination, child's crying at night, etc. (5) Night and day shift worker or manual laborer (6) During the treatment of diseases affecting sleep or pulse, such as sleep apnea syndrome, chronic fatigue syndrome, autonomic imbalance and the like, a subject having a diagnosis history or a subject to be strongly suspected (7) Subjects of constitution / body that are thought to interfere with wearing of wearable activity meter (8) Subjects who may feel stress due to abstinence or quitting smoking and may affect sleep (9) Subjects who have the potential of developing pollinosis during the study (10) Subjects who have under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion (11) Subjects having possibilities for emerging allergy related to the study (12) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (13) Subjects who are judged as unsuitable for the study because of clinical test, anthropometric test and physical examination in pre-inspection (14) Subjects who have participated in other clinical study within the last one month or have plan to participate other clinical studies (15) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study (16) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17) Subjects who are judged as unsuitable for the study by investigator for other reasons

Design outcomes

Primary

MeasureTime frame
OSA sleep inventory MA version, Japanese short version of POMS2

Secondary

MeasureTime frame
Total time of deep sleep, Total time of sleep, sleep latency, LF/HF ratio, HF

Countries

Japan

Contacts

Public ContactShinsuke Tsuji

TTC Co., Ltd. Clinical Research Planning Department

s.tsuji@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026